Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PS in my mind all these short-term perturbations are meaningless in the big scheme of things with Amarin
To each their own Woody. Seriously lots of luck with whatever your strategy is. I don't mean that sarcastically. I just don't worry about these day to day raids. I've got my eye on the future.
Short-term profit-taking. In 2023 this will look like a minor blip
My body does not tolerate statins. I developed severe muscle issues. Lucky to have recovered.
I am currently on Zetia and V, regardless of no study confirming combo.
There are us who are on your side.
Why in the world wouldn't it be on their radar? Surely you can't think they are that stupid. And if you do what are you doing in the stock?
Re RTI, SUIT. Now I've heard everything!
Right on Raf! You put it the way Ive been wanting to put it for a long time now
Baba: good points.
Maybe he meant IF the label is expanded
then hire more reps. At least that would make some sense in the sentence although I can see a case made for taking a risk hiring the reps getting them up to speed
If breakevens going to be so soon why is everybody so worried about Gia? That's a rhetorical question I know the answer. It's because their Xpectations for high Roi are in much too soon a time frame. Patience on this board is practically non-existent.
AMRN When Breakeven? sorry if already posted
can't scan all posts on the prolific board.
https://finance.yahoo.com/news/amarin-corporation-plc-nasdaq-amrn-181011308.html
AMRN is projectec to be break even at some point in early 2020. Not sure if that is EBITA or GAAP. Paying off the loan will be a piece of cake after that
Sorry you feel that way. Just trying to add a little humor and maybe a little different perspective.
If anyone sees the AMRN glass half empty perhaps you what do better to go to a smaller glass.
or go to a different bar.
Amen to the last paragraph bro.
Regarding options I don't have the time to fool with those. Everything has an alternative cost. I prefer spending my precious time on other activities ( with the exception of being entertained by this board occasionally).
Massulo: for reasons in my post #195016
Price Action Theory (admittedly strictly THEORY)
1. Price will retain support in current range because of possiblity of buyout, efficacy of trial, adoption of SOC, and fact the FDA saw fit to give priority review for whatever reasons they saw (likely life savings, etc).
2. Price will be capped in current range until hints of better earnings to support better multiple, probably Q4 2019, Q1 2020.
3. Alternative investments are out there right now.
a. Outlook for trade reconciliations
b., c., etc
Just some results of musing. might be right, might be wrong. Take em or leave em.
HR
xb: good points, makes sense. Thanks
So do these function the same as ETFs? That is if the indexes go down they take Amarin with it?
I believe that there are some funds that trade the index.
Pardon my ignorance, I get confused as to the interaction on some of these funds.
CBB: JT gave EU perspective during the CC Q&A. The rationale for not hitting EU hard (at least at that time in early May) is right there.
I don't remember the exact words, so I am referencing this for you to access if it is still available.
HR
BB I respect your zeal and energy and almost all your contributions to this board. I respectfully BEG you to follow your advice here, (having seen both sides of you). Between doing that and V dosage, you will probably live a long. long time to enjoy the rewards you deserve.
As for me, I am sticking to my campaign promise to be patient and bet on the rewards circa 2023-4, whether GIA or BO. Only nuclear war or a competitive upstart from out of the blue can derail us now.
Understand this is coming from someone about to turn 80, and is viewing AMRN's success at that time as an insurance policy to help support my 73 year old wife whether I am still here at that time or not.
Evidently Amarin is taking the high road with respect to the latest hit piece. Good for them. Rather than honoring that junk with a rebuttal they seem to be relying on their snda submittal and the obvious positive interim response by the FDA. I think this board should take the same approach.
My opinion only.
There's a lot of interests out there with a lot to lose with an AMRN success.
Yes and those with dry powder can use this to their advantage. In a war, the losing army always mounts a last minute counter attack that although has short term wins, ends up costing them dearly.
Looks like Gwen has some juicy meat to sink her teeth into fresh out of the gate with this new bear raid activity
This collaborative bear activity; is anyone on this board aware of similar activities against new bio upstarts?
I'm saying nothing to be afraid of in the long run.
Afraid? What's there to be afraid of?
You may be right. I just hope that if there is a buyout we get at least what I perceive we could have gotten with Gia
It's great except I still haven't figured out how to edit my previous posts within 15 minutes as I can using my computer web page
The news validates the current price based on forward earnings over the next 12 months. If you want a higher price per share you're going to have to wait. You will get it.
Just not yet. Frankly I am looking for close to $100 a share for Gia in 2023.
This is why I think out to 2023. All of these issues such as raw material supply, Market development, revenue and earnings growth should be at Optimum performance at that time. Everything else before then is short-term to me and is in the setup phase..
I've got one for today: PATIENCE
One has to wonder..JT isn't dumb. He seems to be the only one that doesnt appear to be worried. Maybe because he has already cashed in. Or maybe he's the only one with his head on straight. Maybe both. Remember there has been a commitment to do what's in the best interest of the shareholders.
I have to believe that he has a broader perspective than those on this board.
Our interpretation of numbers can lie.
Not so ironic...nice method used to accumulate lots of low priced shares to reach 10% control for a hostile takeover.
Not sure can be done here. I saw some blurbs here recently regarding takeover laws in Ireland.
LMK, I appreciate your input and those of others. Here are #s HDG put forth Last October with some different Revenue, Margin and Rate assumptions.
=================
X bn Net Revenue (equally distributed over 10 years) with 20% COGS, 5bn OPEX (extremely optimistic assumption ...), 12.5% tax and 370M shares (and Y% per year DCF for 10 years) equal with Z net profit per share …
X bn / Y% / $ Z
120 / 5 / 166
120 / 10 / 132
150 / 5 / 210
150 / 10 / 167
200 / 5 / 283
200 / 10 / 225
250 / 5 / 356
250 / 10 / 283
I wasn't challenging your numbers, just asking.
thanks
HRS
LMK: What discount rate did you use?
thanks,
HRS